Protagenic Therapeutics, Inc.
21.3.2024 13:43:15 CET | ACCESS Newswire | Press release
NEW YORK, NY / ACCESSWIRE / March 21, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a biopharmaceutical innovator, regained compliance with Nasdaq Listing Rule 5550(a)(2) as the closing bid price of shares of PTIX has remained above $1.00 per share for ten consecutive trading days. This resolves the issue of potential delisting from Nasdaq by May 19, 2024 that the company had been facing.
On Tuesday, November 21, 2023, the company received a deficiency letter from Nasdaq stating that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market, because it had not maintained a minimum bid price of $1.00 per share for 30 consecutive trading days. The Notification Letter stated that the company had 180 calendar days, or until May 19, 2024, to regain compliance by having a closing bid price of at least $1.00 per share for ten consecutive trading days. On March 19, 2024, the company received a formal notice from Nasdaq confirming that it has regained compliance with Listing Rule 5550(a)(2).
About Protagenic Therapeutics, Inc.:
Protagenic Therapeutics, Inc. (Nasdaq: PTIX) is committed to pioneering neuro-active peptides into therapeutics to mitigate stress-related disorders. For more information, visit www.protagenic.com.
About PT00114:
PT00114, a 41-amino-acid synthetic peptide, holds promise in treating various neuro-psychiatric conditions, including depression, anxiety, and PTSD. It operates with a novel mechanism, mirroring the active part of the natural brain hormone TCAP, thereby reducing circulating cortisol levels.
Forward-Looking Statements:
This press release contains forward-looking statements concerning Protagenic Therapeutics' product candidates and clinical trial plans. These statements are subject to various risks and uncertainties. Investors are urged to exercise caution and not place undue reliance on these forward-looking statements.
Company Contact:
Alexander K. Arrow, MD, CFA Chief Financial Officer Protagenic Therapeutics, Inc. 149 Fifth Ave, Suite 500, New York, NY 10010. Tel: 213-260-4342 Email: alex.arrow@protagenic.com
Investor Relations Contact:
Kirin M. Smith, President, PCG Advisory, Inc. 950 Third Avenue, Suite #2700, New York, NY 10022. Tel: 646-823-8656 Email: ksmith@pcgadvisory.com
SOURCE: Protagenic Therapeutics, Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Learnis: A New International Network for Transformative Education is Born.8.9.2026 23:05:00 CEST | Press release
Three groups of companies from Italy, Spain and the United States unite in a new corporate network structure, strong of a 20-year shared method that converges under one masterbrand - Learnis, Your transformative education. MILAN, IT / ACCESS Newswire / September 8, 2026 / A new corporate structure brings together Genio Net, the Italian business network directed by Massimo De Donno; Crecimiento Personal SL, the company headed by Giacomo Navone as the franchisor of the Spanish network; and Genius in 21 Days LLC, founded in the United States by Stephanie Turconi and Cosimo Intermite. Across the three countries, the group runs more than 50 learning centers, working with certified instructors and tutors, and reaching over 5,000 participants each year with its immersive courses, training paths and publications, with a focus on personalized study methods and learning. The group has chosen to introduce itself publicly on September 8, 2026, the International Literacy Day. Promoted by UNESCO to
TripGift Launches Its Next-Generation Global Travel Value Platform8.9.2026 14:30:00 CEST | Press release
The 103-currency platform brings together global travel gift cards, rewards, incentives, programmable promotional vouchers and travel redemption across more than 180 countries. NEW YORK CITY, NY / ACCESS Newswire / September 8, 2026 / TripGift, the multi-award-winning global Travel Value Platform, today announced the launch of its next-generation platform, expanding how organizations can integrate travel value into customer, partner and employee programs. Building on TripGift's established global travel gifting and redemption capabilities, the platform brings together its eight proprietary travel gift brands, Travel Value API, Purpose-Bound Promotional Vouchers and travel redemption platform. TripGift's market-leading platform enables travel gift cards to be purchased in 103 currencies and redeemed across more than 180 countries, with access to 2.9 million+ travel and lifestyle booking options, including 2.8 million accommodations, 600 airlines, 30,000 mobility locations, 50,000 tours
A New Force in the Surf Park Economy8.9.2026 13:00:00 CEST | Press release
AWM and China Tourism Group launch Eastern Swell Dynamics SOLANA BEACH, CA / ACCESS Newswire / September 8, 2026 / American Wave Machines is pleased to announce the formation of Eastern Swell Dynamics, a new joint venture established with China Tourism Group to support the growth of PerfectSwell® surf pools across China. The new company will serve as the official licensed platform for PerfectSwell® projects in the region, bringing together AWM's proven surf technology with CTG's deep tourism infrastructure, development capabilities, market access and longstanding presence across Greater China. Riyue Bay Surf Resort powered by PerfectSwell® surf technology China Tourism Group is one of the most significant tourism enterprises in China, with a history dating back more than a century and a business network spanning mainland China, and international markets. Its platform includes travel services, scenic destinations, hotels, duty free retail, tourism transportation, real estate, cultural t
OMP Asia Conferences to Showcase How Industry Leaders Kraft Heinz, Mars, Medac, And Nestlé Approach AI-Powered Supply Chain Planning At "Decision Velocity"8.9.2026 11:35:00 CEST | Press release
Events also feature acclaimed keynote speakers Andrea Iorio, author of "Between You and AI" and former Chief Digital Officer at L'Oréal, and Junjun Gao, a leading voice on supply chain digital transformation in China. SINGAPORE, SG / ACCESS Newswire / September 8, 2026 / OMP, a leading provider of supply chain planning solutions, returns to Asia with two OMP Conferences: Singapore on October 15 and Shanghai on October 20, 2026. Under the theme "Decision velocity," the events bring together supply chain leaders, practitioners, and technology experts to explore how AI-enabled planning helps organizations turn insights into action, respond faster to disruption, and advance toward autonomous planning. The program features customer sessions in Singapore with Nestlé, Kraft Heinz, and Medac, in partnership with PwC, and in Shanghai with Dow and Mars. They will share how they are advancing supply chain planning, strengthening capabilities, and using AI and data to make faster, better decisions
Flow Technology partners with BW Forsyth Partners to Meet Growing Demand for Biopharmaceutical Manufacturing7.9.2026 10:00:00 CEST | Press release
Investment supports Flow Technology's ability to help pharmaceutical and biotechnology manufacturers expand production and navigate increasingly complex manufacturing requirements CHARLEVILLE, IRELAND / ACCESS Newswire / September 7, 2026 / Flow Technology, a provider of engineered process systems and skid integration solutions serving the global life sciences industry, announced a partnership with BW Forsyth Partners that will support the company's continued expansion in the United States and Europe, and enhance its ability to serve the evolving needs of global pharmaceutical and biotechnology manufacturers. The partnership comes as pharmaceutical and biotechnology companies invest heavily in production capacity, advanced manufacturing technologies and domestic supply chains. Flow Technology's expertise in downstream purification, filtration and chromatography systems positions the company to support the increasingly sophisticated process infrastructure required to manufacture next-ge
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom